IGF1 (Insulin-like growth factor 1)

News alerts, weekly reports and conference planners

Entrez ID:

IGF1 rs6220	Colorectal Cancer	IGF1 rs6220	Colorectal Cancer	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3
IGF1 elevation	Ewing Sarcoma	IGF1 elevation	Ewing Sarcoma	CP-751,871 Sensitive: C3 – Early Trials CP-751,871 Sensitive : C3	CP-751,871 Sensitive: C3 – Early Trials CP-751,871 Sensitive : C3
IGF1 rs2016347	Breast Cancer	IGF1 rs2016347	Breast Cancer	tamoxifen Resistant: C3 – Early Trials tamoxifen Resistant : C3	tamoxifen Resistant: C3 – Early Trials tamoxifen Resistant : C3
IGF1 elevation	Pancreatic Cancer	IGF1 elevation	Pancreatic Cancer	AMG 479 Sensitive: C3 – Early Trials AMG 479 Sensitive : C3	AMG 479 Sensitive: C3 – Early Trials AMG 479 Sensitive : C3
IGF1 rs2946834	Colorectal Cancer	IGF1 rs2946834	Colorectal Cancer	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3
IGF1 overexpression	Prostate Cancer	IGF1 overexpression	Prostate Cancer	enzalutamide + BI-836845 Sensitive: C3 – Early Trials enzalutamide + BI-836845 Sensitive : C3	enzalutamide + BI-836845 Sensitive: C3 – Early Trials enzalutamide + BI-836845 Sensitive : C3

Associations(6)